PERMANTIS

What this means for you

Not registered yet, but its 14 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98269397

Mark type

Stylized text

Filed

14 Nov 2023

Published for opposition

07 Jan 2025

Attorney of record

R. Gwen Peterson

Goods and services

• Class 001 — Chemicals: Diagnostic preparations for scientific research purposes other than for medical or veterinary purposes; biological preparations for scientific research purposes other than for medical or veterinary use; diagnostic test kits used for providing clinical scientific laboratory services according to laboratory standards regulated by a governmental entity, namely, for the detection of diseases, disorders, and conditions
• Class 005 — Pharmaceuticals: Diagnostic preparations for clinical medical use purposes, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic preparations and biological reagents for clinical medical purposes, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; pharmaceutical preparations for medical use, namely, the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; pharmaceutical preparations for medical use, namely, the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in clinical examination according to laboratory standards regulated by a governmental entity, for the detection of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in clinical examination according to laboratory standards regulated by a governmental entity, for the detection of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins
• Class 035 — Advertising and business services: Promoting the services of others, namely, technical and scientific investigation, research and experimentation in the field of genomics; promoting the services of others, namely technical and scientific investigation, research and experimentation in the field of patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of diseases, disorders and conditions
• Class 036 — Insurance and financial services: Financial asset management and investment management services; financial services, namely, private equity fund investments and funding research awards in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; capital investment services, namely, investing in technologies focused on the detection, disruption, prevention and treatment of diseases, disorders and conditions; financial services, namely, business fundraising for others; business fundraising for others to support scientific and medical research and procedures; capital investment services
• Class 042 — Scientific and technological services: Biological, medical, and pharmaceutical research and development; providing medical and scientific research and medical and scientific information; scientific and medical research and consulting in the field of genomics; scientific and medical research and consulting focused on the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; scientific and medical research and consulting focused on the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; technical scientific research and medical research services focused on patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; technical scientific research and medical research services focused on patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; research, design, development and testing services in the field of diagnostics, biologics and therapeutics for the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; research, design, development and testing services in the field of diagnostics, biologics and therapeutics for the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; providing laboratory research services in the fields of genomics and the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; providing laboratory research services in the fields of genomics and the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; providing medical and scientific research information in the fields of genomics and the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions caused by infectious agents, diseases, disorders and conditions found in neonates and children, and autoimmune, atopic and inflammatory diseases, disorders and conditions; providing medical and scientific research information in the fields of genomics and the detection, disruption, prevention and treatment of various diseases, disorders and conditions, namely, diseases, disorders and conditions relating to pregnancy, women's health, psychiatric issues and psychiatric treatment, cancer and cancer treatment, cardiovascular issues, renal issues, gastrointestinal issues, metabolic issues, issues related to aging, hematological issues, genetic issues, nutritional issues, issues relating to bioterrorism and other man-made threats, and issues relating to poisons and toxins; compiling of biological and statistical data for research purposes in the field of medical science and medical consultancy; providing clinical scientific laboratory services for others according to laboratory standards regulated by a governmental entity; Medical testing for diagnostic purposes under laboratory standards regulated by a governmental entity; Providing medical and scientific research information, namely, nucleic acid sequencing and analysis services under laboratory standards regulated by a governmental entity
• Class 045 — Legal and security services: Licensing of intellectual property rights

Owner

• Permantis LLC, San Carlos, CA, US
• Permantis LLC, San Carlos, CA, US

Prosecution history

• 05 Feb 2026 — SOU EXTENSION 2 GRANTED
• 05 Feb 2026 — SOU EXTENSION 2 FILED
• 05 Feb 2026 — SOU TEAS EXTENSION RECEIVED
• 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 31 Aug 2025 — SOU EXTENSION 1 GRANTED
• 31 Aug 2025 — SOU EXTENSION 1 FILED
• 31 Aug 2025 — SOU TEAS EXTENSION RECEIVED
• 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 07 Jan 2025 — PUBLISHED FOR OPPOSITION
• 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 12 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 10 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 10 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 10 Dec 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED